ICD-10-CM C46 is the diagnosis code for Kaposi's sarcoma. This code falls under the section "Malignant neoplasms of mesothelial and soft tissue" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where C46 sits in the ICD-10-CM classification helps ensure proper coding:
No, C46 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C46 is the ICD-10-CM diagnosis code for "Kaposi's sarcoma". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C46 is located in Section C45-C49 — "Malignant neoplasms of mesothelial and soft tissue" within Chapter 2 of the ICD-10-CM Tabular List.
C46 has 8 sub-code(s) that provide more specific detail: C46.0, C46.1, C46.2, C46.3, C46.4 and more.
Use C46 when the patients documented diagnosis matches "Kaposi's sarcoma" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Kaposi's sarcoma is C46.
No, C46 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C46 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C46 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.